tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Viatris announces FDA acceptance of review for MR-141 sNDA
PremiumThe FlyViatris announces FDA acceptance of review for MR-141 sNDA
7d ago
Is VTRS a Buy, Before Earnings?
Premium
Pre-Earnings
Is VTRS a Buy, Before Earnings?
8d ago
Viatris upgraded to Buy from Neutral at UBS
Premium
The Fly
Viatris upgraded to Buy from Neutral at UBS
23d ago
Argus upgrades Viatris to Buy on expected buybacks, debt reduction
PremiumThe FlyArgus upgrades Viatris to Buy on expected buybacks, debt reduction
2M ago
Viatris upgraded to Buy from Hold at Argus
Premium
The Fly
Viatris upgraded to Buy from Hold at Argus
2M ago
Viatris says no longer going through period of revenue, EBITDA decline
Premium
The Fly
Viatris says no longer going through period of revenue, EBITDA decline
2M ago
Viatris Sells Biocon Biologics Stake for $815 Million
PremiumCompany AnnouncementsViatris Sells Biocon Biologics Stake for $815 Million
3M ago
Viatris to sell equity stake in Biocon Biologics to Biocon for $815M
Premium
The Fly
Viatris to sell equity stake in Biocon Biologics to Biocon for $815M
3M ago
Viatris Holds Annual Shareholder Meeting on December 5
Premium
Company Announcements
Viatris Holds Annual Shareholder Meeting on December 5
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100